Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)
Close on Nov 17, 2026Market cap $4.48BP/E –Yield –
Ionis Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ionis Pharmaceuticals's price to sales ratio was 5.4× on Nov 11, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 5.4× to 14.0×, with a median of 8.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.4× | −7.8 |
| 2025 | Dec 31, 2025 | 13.2× | +6.3 |
| 2024 | Dec 31, 2024 | 6.9× | −4.9 |
| 2023 | Dec 29, 2023 | 11.8× | +5.7 |
| 2022 | Dec 30, 2022 | 6.1× | −0.4 |
| 2021 | Dec 31, 2021 | 6.5× | −2.0 |
| 2020 | Dec 31, 2020 | 8.5× | −1.9 |
| 2019 | Dec 31, 2019 | 10.3× | −2.6 |
| 2018 | Dec 31, 2018 | 12.9× | +0.6 |
| 2017 | Dec 29, 2017 | 12.4× | −12.0 |
| 2016 | Dec 30, 2016 | 24.4× | +0.9 |
| 2015 | Dec 31, 2015 | 23.4× | −19.0 |
| 2014 | Dec 31, 2014 | 42.5× | +5.5 |
| 2013 | Dec 31, 2013 | 37.0× | +27.8 |
| 2012 | Dec 31, 2012 | 9.2× | +1.5 |
| 2011 | Dec 30, 2011 | 7.7× | −1.1 |
| 2010 | Dec 31, 2010 | 8.8× | −1.0 |
| 2009 | Dec 31, 2009 | 9.8× | – |
See a number that looks wrong?